Literature DB >> 16772849

Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism.

Karen C Briley-Saebo1, Lars O Johansson, Svein Olaf Hustvedt, Anita G Haldorsen, Atle Bjørnerud, Zahi A Fayad, Haakan K Ahlstrom.   

Abstract

OBJECTIVES: We sought to evaluate the effect of the particle size and coating material of various iron oxide preparations on the rate of rat liver clearance.
MATERIALS AND METHODS: The following iron oxide formulations were used in this study: dextran-coated ferumoxide (size = 97 nm) and ferumoxtran-10 (size = 21 nm), carboxydextran-coated SHU555A (size = 69 nm) and fractionated SHU555A (size = 12 nm), and oxidized-starch coated materials either unformulated NC100150 (size = 15 nm) or formulated NC100150 injection (size = 12 nm). All formulations were administered to 165 rats at 2 dose levels. Quantitative liver R2* values were obtained during a 63-day time period. The concentration of iron oxide particles in the liver was determined by relaxometry, and these values were used to calculate the particle half-lives in the liver.
RESULTS: After the administration of a high dose of iron oxide, the half-life of iron oxide particles in rat liver was 8 days for dextran-coated materials, 10 days for carboxydextran materials, 14 days for unformulated oxidized-starch, and 29 days for formulated oxidized-starch.
CONCLUSIONS: The results of the study indicate that materials with similar coating but different sizes exhibited similar rates of liver clearance. It was, therefore, concluded that the coating material significantly influences the rate of iron oxide clearance in rat liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772849     DOI: 10.1097/01.rli.0000221321.90261.09

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  24 in total

Review 1.  Biologically optimized nanosized molecules and particles: more than just size.

Authors:  Michelle R Longmire; Mikako Ogawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2011-05-11       Impact factor: 4.774

Review 2.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

Review 3.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke
Journal:  Chem Soc Rev       Date:  2011-05-23       Impact factor: 54.564

4.  Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging.

Authors:  Karen C Briley-Saebo; Marylene Leboeuf; Stephen Dickson; Venkatesh Mani; Zahi A Fayad; A Karolina Palucka; Jacques Banchereau; Miriam Merad
Journal:  Magn Reson Med       Date:  2010-11       Impact factor: 4.668

Review 5.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

Review 6.  Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.

Authors:  Karen Briley-Saebo; Calvin Yeang; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Cardiovasc Transl Res       Date:  2014-10-09       Impact factor: 4.132

7.  Delayed hepatic signal recovery on ferucarbotran-enhanced magnetic resonance images in a rat model with regional liver irradiation.

Authors:  Toshihiro Furuta; Masayuki Yamaguchi; Ryutaro Nakagami; Masaaki Akahane; Manabu Minami; Kuni Ohtomo; Hirofumi Fujii
Journal:  MAGMA       Date:  2014-02-26       Impact factor: 2.310

8.  Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging.

Authors:  Benjamin R Jarrett; Björn Gustafsson; David L Kukis; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2008-06-26       Impact factor: 4.774

Review 9.  Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Dalong Ni; Wenbo Bu; Emily B Ehlerding; Weibo Cai; Jianlin Shi
Journal:  Chem Soc Rev       Date:  2017-11-27       Impact factor: 54.564

Review 10.  An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.

Authors:  Martina A McAteer; Asim M Akhtar; Constantin von Zur Muhlen; Robin P Choudhury
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.